Atlas Arteria Limited (ALX.AX)

AUD 4.59

(0.44%)

EBITDA Summary of Atlas Arteria Limited

  • Atlas Arteria Limited's latest annual EBITDA in 2023 was 98.6 Million AUD , up 49.43% from previous year.
  • Atlas Arteria Limited's latest quarterly EBITDA in 2024 Q2 was 32.1 Million AUD , down 0.0% from previous quarter.
  • Atlas Arteria Limited reported an annual EBITDA of 63.06 Million AUD in 2022, up 17.32% from previous year.
  • Atlas Arteria Limited reported an annual EBITDA of -11.95 Million AUD in 2021, down -0.49% from previous year.
  • Atlas Arteria Limited reported a quarterly EBITDA of N/A for 2023 FY, up 49.43% from previous quarter.
  • Atlas Arteria Limited reported a quarterly EBITDA of 30.6 Million AUD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Atlas Arteria Limited (2023 - 2010)

Historical Annual EBITDA of Atlas Arteria Limited (2023 - 2010)

Year EBITDA EBITDA Growth
2023 98.6 Million AUD 49.43%
2022 63.06 Million AUD 17.32%
2021 -11.95 Million AUD -0.49%
2020 -93.67 Million AUD -45.71%
2019 -99.05 Million AUD 378.09%
2018 218.46 Million AUD -256.07%
2017 593.3 Million AUD -96.08%
2016 -166.4 Million AUD 250.93%
2015 -28.9 Million AUD 237.54%
2014 -82.38 Million AUD -250.16%
2013 -11.5 Million AUD -157.12%
2012 31.49 Million AUD 91.46%
2011 -84.22 Million AUD 11.91%
2010 87.08 Million AUD 0.0%

Peer EBITDA Comparison of Atlas Arteria Limited

Name EBITDA EBITDA Difference
Ariadne Australia Limited 4.55 Million AUD -2064.654%
AVADA Group Limited 15.66 Million AUD -529.589%
Transurban Group 2.5 Billion AUD 96.069%
Ventia Services Group Limited 461.6 Million AUD 78.64%